Tilray Stock News

Fire & Flower Holdings Corp. said it has filed to list its stock on the Nasdaq as the latest Canadian pot company to trade on a major U.S. exchange after Tilray , Canopy Growth , Aurora Cannabis , Cronos Group , OrganiGram Holdings and others. "Listing on the Nasdaq will allow us to expand our shareholder base and drive increased shareholder value as we continue to leverage our unique technology-driven business model to enter new targeted markets across North America," Fire & Flower CEO Trevor Fencott said in a statement on Wednesday. The company said it would announce when its stock will officially start trading on the Nasdaq and did not yet disclose its Nasdaq ticker symbol. OTC-listed shares of Fire & Flower are up 4% so far in 2022 and down 44% in the past 12 months, compared to a loss of nearly 8% in 2022 and a drop of 56% in the past 12 months by the Cannabis ETF . Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Tilray expects to see $1 billion in revenue from Europe once legalization efforts come to fruition.

Tilray Inc - Class 2 (TLRY) shares closed today 13.6% higher than it did at the end of yesterday. The stock is currently up 3.7% year-to-date, down 35.5% over the past 12 months, and down 67.4% over the past five years. Today, the Dow Jones Industrial Average fell 0.4%, and the S&P 500 fell 0.1%. Trading Activity Shares traded as high as $7.84 and as low as $6.29 this week.Shares closed 89.1% below its 52-week high and 15.9% above its 52-week low.Trading volume this week was 30.8% lower than the 10-day average and 5.2% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Materials industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -185.6% The company's stock price performance over the past 12 months lags the peer average by 90.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

The pivot to a brand focus comes at a time when the cannabis industry has grown immensely but there are still few recognizable product names

U.S. markets took a beating Monday morning, but all three major indexes were clawing back some gains for morning lows.

These are the stocks posting the largest moves in midday trading.

All eyes are on Tilray price predictions after the company reported earnings that reached profitability. Will 2022 be a turnaround story?

Tilray is looking beyond Canada''s disappointing cannabis market as marijuana legalization expands across the globe. Germany looks like a big prize.

Corporate results, both actual and predicted, spurred trading in Monday''s pre-market action

Tilray, Inc. (NASDAQ: TLRY ) (TSX: TLRY) reported Monday its financial results for the second fiscal quarter ended November 30, 2021, with net revenue of $155 million, up by around 20% from $129 million in the same period year ago and down from $168 million in the first fiscal quarter . The Canadian marijuana giant also announced a new parent name, Tilray Brands, Inc ., reflecting the companys evolution from a Canadian LP to a global consumer packaged goods company with a portfolio of cannabis and lifestyle CPG brands. Q2 Financial Highlights Net income increased to $6 million from a net loss of $89 million in the previous year quarter; Adjusted EBITDA was of $13.8 million , representing 8% growth compared to the preceding prior quarter and making for the eleventh consecutive quarter of positive Adjusted EBITDA; Gross profit of $32.8 million was a 7% decrease from $35.3 million in the prior-year quarter; Adjusted gross margin in the cannabis segment Full story available on Benzinga.